Work

Effects of randomization to buprenorphine or naltrexone for OUD on cannabis use outcomes: A secondary analysis of the X:BOT trial

Year: 2025

Type: article

Source: Drug and Alcohol Dependence

DOI: 10.1016/j.drugalcdep.2025.112550

Authors: Matisyahu Shulman, Tse-Hwei Choo, Kaitlyn Ohrtman, Martina Pavlicova, John Rotrosen, Edward V. Nunes

Institutions: Columbia University Irving Medical Center, New York State Psychiatric Institute, Columbia University, New York University

Language: English

Topic: Opioid Use Disorder Treatment

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Institute on Drug Abuse

Awards: Translational Clinical Research Fellowship on Substance Use Disorders, NIDA Clinical Trials Network: New York Node - Renewal-GY24

OpenAlex ID: W4406549841

FWCI: 0.903

Cites: 25

Cited by: 1

Related to: 10